SCHEMBL27403161

SCHEMBL27403161

CNc1cc(N2CCOCC2)ccc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.52
MAPT P10636 8/20 0.51
MEN1 O00255 8/20 0.51
KMT2A Q03164 8/20 0.51
ALDH1A1 P00352 7/20 0.51
PKM P14618 1/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
GAA P10253 1/20 0.50
KIT P10721 1/20 0.49
FLT3 P36888 1/20 0.49
IRAK4 Q9NWZ3 1/20 0.49
KDM4E B2RXH2 3/20 0.49
THRB P10828 2/20 0.49
HTT P42858 2/20 0.49
INSR P06213 1/20 0.48
ALK Q9UM73 1/20 0.48
HIF1A Q16665 2/20 0.47
HPGD P15428 2/20 0.47
HSD17B10 Q99714 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24590200 0.88 LRRK2 (0.61) LRRK2MAPTMEN1KMT2AALDH1A1
SCHEMBL13225331 0.83 HTR6 (0.64) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL19500869 0.82 HIF1A (0.62) MAPTMEN1KMT2AALDH1A1PKM
SCHEMBL16106421 0.82 MAPT (0.58) MAPTMEN1KMT2AALDH1A1PKM
SCHEMBL3042603 0.81 ALDH1A1 (0.54) MAPTMEN1KMT2AALDH1A1PKM
SCHEMBL172879 0.80 MAPT (0.59) MAPTMEN1KMT2AALDH1A1PKM
SCHEMBL2498472 0.78 MAPT (0.63) MAPTMEN1KMT2AALDH1A1PKM
SCHEMBL1232770 0.78 LGMN (0.57) MAPTMEN1KMT2AALDH1A1PKM
SCHEMBL1599724 0.78 PRKDC (0.57) MAPTMEN1KMT2AALDH1A1PKM
SCHEMBL14180563 0.78 LRRK2 (0.52) LRRK2MAPTMEN1KMT2AIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208934-A1 ULK1/2 INHIBITORS AND THEIR USE THEREOF LIFEARC (GB) 2024-06-27 US disclosed
US-20240208934-A1 ULK1/2 INHIBITORS AND THEIR USE THEREOF LIFEARC (GB) 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208934-A1 ULK1/2 INHIBITORS AND THEIR USE THEREOF ULK1, ULK2, ULK3 LRRK2 827/4885MAPT 717/4885MEN1 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.